Clinical trials
Intubation; Difficult or Failed clinical trials
Below are recruiting intubation; difficult or failed clinical trials, each written for real people, not researchers. We’re tracking 152 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06945029Recruiting
Comparing two airway devices for children having surgery
This study compares two devices used to help children breathe during surgery. It will see which one works best for placing a breathing tube through a scope in children aged 4 to 8 years old.
Cairo, Giza GovernorateAges 4–8 - NCT07021534RecruitingPhase 1
CAR-NK and CAR-T cells for cancer with liver spread
This trial tests a new treatment that uses special immune cells (CAR-NK and CAR-T cells) given directly into the liver artery, then through a vein, to fight advanced solid tumors that have spread to the liver. It is for people who have already tried standard treatments and need new options.
Hangzhou, ZhejiangAges 18–75 - NCT07017283Recruiting
Comparing two sedation methods for older adults having ERCP
This study compares two ways of keeping you comfortable and safe during an ERCP procedure: deeper sedation with a breathing tube versus deep sedation without a breathing tube. It aims to find which method causes fewer side effects in older adults.
Hangzhou, ZhijiangAges 60 years+ - NCT06955884Recruiting
Awake breathing tube: mouth vs. nose
This trial compares two ways of placing a breathing tube in patients who have a difficult airway and need surgery. One method goes through the mouth, the other through the nose, both while you are awake. The goal is to see which method you prefer.
Hamburg, Free and Hanseatic City of HamburgAges 18 years+ - NCT06940219Recruiting
Comparing delayed vs. rapid intubation in emergencies
This trial tests whether delaying medication to start breathing support (by waiting 60 seconds after sedation) is safer for critically ill adults needing emergency intubation. Standard practice is to give sedation then immediately insert the tube.
Leipzig, SaxonyAges 18 years+ - NCT06745908RecruitingPhase 3
New drug combo for lung cancer after immunotherapy stops working
This trial tests a new drug combination (N-803 and tislelizumab with chemotherapy) for people whose lung cancer stopped responding to standard immunotherapy. The goal is to see if this treatment can help shrink tumors or slow the cancer's growth.
Springdale, ArkansasAges 18–90 - NCT05967507Recruiting
Testing oxygen flow during infant airway tube placement
This trial studies how different oxygen flow rates affect breathing during the process of placing a breathing tube in babies. It may help clinicians choose safer oxygen settings during routine and urgent (but not life-threatening) airway management.
Philadelphia, PennsylvaniaAges Up to 12 months - NCT05347732Recruiting
Finds why heart clot treatment may not work
This study looks at people with a specific type of heart attack who received clot-busting treatment before reaching the hospital. It aims to figure out what predicts why the treatment might fail, which could help improve care in the future.
OsloAges 18 years+ - NCT05838365RecruitingPhase 4
Earlier vs later placement of single tooth implants
This study compares two timing approaches for placing a single implant tooth: putting the implant load (chewing force) on it sooner versus later. It may help show which timing works best for healing and long-term comfort in people with suitable bone and gum tissue.
MilanAges 18–80 - NCT06102759Recruiting
Study of adebrelimab and fruquintinib plus chemo for advanced stomach cancer after PD-1 failure
This trial tests a combination of two targeted drugs (adebrelimab and fruquintinib) plus chemotherapy (paclitaxel or albumin-bound paclitaxel) for people with advanced gastric or gastroesophageal junction cancer whose disease progressed after prior PD-1 antibody treatment. The goal is to see if this new combination can help when standard options have stopped working.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT06123221Recruiting
Sinus lift study: comparing two dental implant techniques
This study compares two methods for lifting the sinus floor to place dental implants. It is for people who need an implant in the upper jaw but don't have enough bone height. The goal is to see which technique works better.
Porto Alegre, Rio Grande do SulAges 18 years+ - NCT05275088Recruiting
Transcatheter valve replacement for badly calcified heart valves
This trial tests Prizvalve, a catheter-based procedure to replace a severely damaged “atrioventricular” valve in people at high risk from open-heart surgery. It may help reduce symptoms caused by valve narrowing or leaking when traditional surgery is not a good option.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT05326880Recruiting
Long-term follow-up comparing zirconia and titanium dental implants
This study checks how well two kinds of dental implants (zirconia and titanium) work over 5 years in replacing a single tooth. You may be included if you already received the specific implant type and restoration the study requires and you can attend regular checkups.
DüsseldorfAges 18 years+ - NCT05427383RecruitingPhase 2/Phase 3
KN026 plus chemo for HER2-positive stomach cancer after first treatment failure
This trial tests KN026 together with chemotherapy in people with HER2-positive advanced stomach (or gastro-esophageal junction) cancer that has already grown despite first-line treatment with trastuzumab plus chemotherapy. It may help by targeting HER2 while also using chemotherapy to control the cancer.
BeijingAges 18 years+ - NCT07868874Enrolling by invitation
Two versus four weeks of stent before ureteroscopy
This study compares leaving a ureteral stent in place for two weeks versus four weeks before a second procedure to remove kidney stones. The goal is to see which waiting time makes the second procedure easier and safer.
Islamabad, FedralAges 18–65 - NCT04656184RecruitingPhase 3
Anakinra vs IVIG for kids who don’t respond to first IVIG
This study compares two treatments—anakinra and IVIG—for children with Kawasaki disease who still have fever after their first standard IVIG treatment. It aims to find which option works better and is safer for “IVIG non-responders” who may be at risk for heart complications.
Le Kremlin-Bicêtre, Val De MarneAges 3 months–17 years - NCT06155396RecruitingPhase 2
Targeted drug combo for advanced cervical cancer
This trial tests a combination of two drugs: an antibody-drug conjugate (RC48-ADC) that targets HER2 on cancer cells, plus an immunotherapy (Zimberelimab) that helps your immune system attack the cancer. It is for people with advanced cervical cancer whose prior platinum-based chemotherapy has stopped working.
Bengbu, AnhuiAges 18 years+ - NCT06445803RecruitingPhase 1
CAR-T therapy for adults with certain blood cancers
This trial tests a type of immunotherapy called CAR-T cells that target two proteins (CD19 and CD22) on cancer cells. It may be an option for adults with B-cell acute lymphoblastic leukemia (ALL) or B-cell non-Hodgkin lymphoma (NHL) that has come back or not responded to earlier treatments.
Nanchang, JiangxiAges 18 years+ - NCT06467500RecruitingPhase 2
Cadonilimab plus chemo for lung cancer after immunotherapy
This trial tests a new drug called cadonilimab combined with chemotherapy for people with advanced lung cancer who have already tried and failed immunotherapy. It aims to see if this combination can help when standard immunotherapy no longer works.
YichangAges 18–75 - NCT06478472Recruiting
Orelabrutinib plus rituximab for marginal zone lymphoma
This trial tests a combination of two targeted therapies—oralebrutinib (a pill that blocks a protein in cancer cells) and rituximab (an antibody infusion)—for people with marginal zone lymphoma that has returned or cannot be treated with local therapies. The goal is to see if this combo works well and is safe.
Xiamen, FujianAges 18 years+ - NCT07787468Enrolling by invitation
Videolaryngoscopes for airway management in severely obese patients
This study compares different videolaryngoscopes for airway management during bariatric surgery in people with severe obesity, aiming to improve safety and ease of intubation.
Radom, Masovian VoivodeshipAges 18 years+ - NCT01390675Recruiting
Registry for heart valve replacement anesthesia during TAVR
This study tracks patients who get a transcatheter aortic valve implantation (TAVR), a procedure to replace a narrowed heart valve without open-heart surgery. It looks at the type of anesthesia used during the procedure and records outcomes to learn what works best for patients.
Munich, BavariaAges 18 years+ - NCT07762170RecruitingPhase 4
Steroid injections for back and pelvic pain
This study is testing how well and how safely steroid injections work for different types of back pain. If you join, you'll receive the injection as part of your care and fill out surveys about your pain and ability to do daily activities before and after.
Thornhill, OntarioAges 18 years+ - NCT07733245Enrolling by invitationPhase 3
Muscle relaxant HRS-9190 for general anesthesia surgery
This study tests a new medicine (HRS-9190) that helps relax muscles during surgery. It is for people having a planned surgery that lasts 1.5 to 4 hours under general anesthesia with a breathing tube. The goal is to see if the medicine works well and is safe.
Changsha, HunanAges 18–75
Hear when a new Intubation; Difficult or Failed trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for intubation; difficult or failed?
- Yes. Clin2 currently lists 152 recruiting intubation; difficult or failed studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a intubation; difficult or failed trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a intubation; difficult or failed trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.